Novel Anticoagulants in Atrial Fibrillation

Summary of the Presentations from the Daiichi Sankyo Symposium, AHA Congress 2013, Dallas, Texas, USA 

Chairperson: Eugene Braunwald1
Speakers: Elaine Hylek,2 Jeffrey Weitz,3 Robert Giugliano,4 Christian Ruff,5 John Camm6

1. Professor of Medicine, Harvard Medical School, Boston, USA
2. Professor of Medicine, Boston University, Boston, USA
3. Professor of Medicine and Biochemistry, McMaster University, Hamilton, Ontario, Canada 4. Associate Professor of Medicine, Harvard Medical School, Cambridge, Massachusetts, USA 5. Physician in the Department of Cardiology, Brigham and Womens’ Hospital, Boston, Massachusetts, USA
6. Professor of Clinical Cardiology, St George’s Hospital, University of London, London, UK

Citation: EMJ Cardiol;1(Suppl 1):8-11

Meeting Summary

This educational seminar, supported by an independent educational grant from Daiichi Sankyo, was held at the AHA congress in Dallas on 19th November 2013. The meeting provided clinicians with an update on the pharmacokinetics and pharmacodynamics of new anticoagulant drugs. The speakers also discussed how best to use these agents according to the latest evidence.

Download (PDF, 71KB)

Leave a Reply